US Stock MarketDetailed Quotes

ARTL Artelo Biosciences

Watchlist
  • 1.1300
  • -0.0200-1.74%
Close Nov 21 16:00 ET
3.65MMarket Cap-393P/E (TTM)

Artelo Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-54.28%1.2M
40.81%2.51M
12.96%2.59M
-3.47%9.93M
-6.79%3.24M
9.19%2.61M
-27.80%1.78M
17.78%2.29M
154.50%10.29M
84.22%3.48M
Selling and administrative expenses
-15.45%870K
-19.86%827K
2.37%1.08M
-29.00%4.23M
-36.23%1.12M
-21.81%1.03M
-27.07%1.03M
-28.68%1.06M
184.22%5.96M
37.64%1.75M
-General and administrative expense
-15.45%870K
-19.86%827K
2.37%1.08M
-29.00%4.23M
-36.23%1.12M
-21.81%1.03M
-27.07%1.03M
-28.68%1.06M
184.22%5.96M
37.64%1.75M
Research and development costs
-79.50%325K
124.07%1.69M
22.02%1.51M
31.73%5.7M
23.06%2.12M
47.03%1.59M
-28.79%752K
166.16%1.24M
122.43%4.32M
180.44%1.73M
Operating profit
54.28%-1.2M
-40.81%-2.51M
-12.96%-2.59M
3.47%-9.93M
6.79%-3.24M
-9.19%-2.61M
27.80%-1.78M
-17.78%-2.29M
-154.50%-10.29M
-84.22%-3.48M
Net non-operating interest income expense
0
-400.00%-3K
0
Non-operating interest income
----
----
----
--0
----
----
----
----
100.00%2K
--0
Non-operating interest expense
----
----
----
--0
----
----
----
----
--5K
--0
Other net income (expense)
-61.82%63K
-57.30%79K
-14.52%106K
209.66%641K
21.90%167K
139.13%165K
780.95%185K
720.00%124K
3,350.00%207K
43,046.71%137K
Gain on sale of security
-61.82%63K
-57.30%79K
-14.52%106K
209.66%641K
21.90%167K
139.13%165K
780.95%185K
720.00%124K
3,350.00%207K
43,046.71%137K
Income before tax
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
Net income continuous Operations
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
Minority interest income
Net income attributable to the parent company
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
Basic earnings per share
57.83%-0.35
-33.93%-0.75
-2.63%-0.78
11.80%-3.14
16.10%-0.99
-1.22%-0.83
35.63%-0.56
-8.57%-0.76
-96.69%-3.56
-15.69%-1.18
Diluted earnings per share
57.83%-0.35
-33.93%-0.75
-2.63%-0.78
11.80%-3.14
16.10%-0.99
-1.22%-0.83
35.63%-0.56
-8.57%-0.76
-96.69%-3.56
-15.69%-1.18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -54.28%1.2M40.81%2.51M12.96%2.59M-3.47%9.93M-6.79%3.24M9.19%2.61M-27.80%1.78M17.78%2.29M154.50%10.29M84.22%3.48M
Selling and administrative expenses -15.45%870K-19.86%827K2.37%1.08M-29.00%4.23M-36.23%1.12M-21.81%1.03M-27.07%1.03M-28.68%1.06M184.22%5.96M37.64%1.75M
-General and administrative expense -15.45%870K-19.86%827K2.37%1.08M-29.00%4.23M-36.23%1.12M-21.81%1.03M-27.07%1.03M-28.68%1.06M184.22%5.96M37.64%1.75M
Research and development costs -79.50%325K124.07%1.69M22.02%1.51M31.73%5.7M23.06%2.12M47.03%1.59M-28.79%752K166.16%1.24M122.43%4.32M180.44%1.73M
Operating profit 54.28%-1.2M-40.81%-2.51M-12.96%-2.59M3.47%-9.93M6.79%-3.24M-9.19%-2.61M27.80%-1.78M-17.78%-2.29M-154.50%-10.29M-84.22%-3.48M
Net non-operating interest income expense 0-400.00%-3K0
Non-operating interest income --------------0----------------100.00%2K--0
Non-operating interest expense --------------0------------------5K--0
Other net income (expense) -61.82%63K-57.30%79K-14.52%106K209.66%641K21.90%167K139.13%165K780.95%185K720.00%124K3,350.00%207K43,046.71%137K
Gain on sale of security -61.82%63K-57.30%79K-14.52%106K209.66%641K21.90%167K139.13%165K780.95%185K720.00%124K3,350.00%207K43,046.71%137K
Income before tax 53.78%-1.13M-52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M
Income tax 0000000000
Net income 53.78%-1.13M-52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M
Net income continuous Operations 53.78%-1.13M-52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M
Minority interest income
Net income attributable to the parent company 53.78%-1.13M-52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 53.78%-1.13M-52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M
Basic earnings per share 57.83%-0.35-33.93%-0.75-2.63%-0.7811.80%-3.1416.10%-0.99-1.22%-0.8335.63%-0.56-8.57%-0.76-96.69%-3.56-15.69%-1.18
Diluted earnings per share 57.83%-0.35-33.93%-0.75-2.63%-0.7811.80%-3.1416.10%-0.99-1.22%-0.8335.63%-0.56-8.57%-0.76-96.69%-3.56-15.69%-1.18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data